SG
CH EN SG MY

Multicenter Prospective Cohort Study of the Incidence of Adverse Events Associated With Cosmetic Der

Murad Alam, MD, MSCI; Rohit Kakar, MD; Michael Nodzenski, BA; Omer Ibrahim, MD; Wareeporn Disphanurat, MD; Diana Bolotin, MD, PhD; Judy H. Borovicka, MD; Natalie Pace, BS; Tina S. Alster, MD; Kenneth A. Arndt, MD; Kenneth R. Beer, MD; Joshua M. Berlin, MD

Injection technique in neurotoxins and fillers: Indications, products, and outcomes

Murad Alam, MD, MBA, MSCI, and Rebecca Tung, MD Chicago and Maywood, Illinois

Injectable fillers and neuromodulators are used for a range of indications pertaining to the correction of facial aging and disfigurement. Fillers can correct soft tissue loss, depressed scars, and atrophy or asymmetry induced by systemic or local disease

A Decade of Experience with Injectable Poly-L-Lactic Acid: A Focus on Safety

CYNTHIA BARTUS, MD, C. WILLIAM HANKE, MD, AND ELIZABETH DARO-KAFTAN, PHD

Important lessons have been learned in the use of injectable PLLA that have helped reduce the frequency of adverse events and make it desirable for restoring facial volume (Table 1). The importance of diffuse distribution of the injectable PLLA suspension

Randomized, Controlled, Multicentered, Double-Blind Investigation of Injectable Poly-L-Lactic Acid f

Krista Bohnert, BS, Andrew Dorizas, MD, Paul Lorenc, MD, and Neil S. Sadick, MD

At the 12-month follow-up, there was a statistically significant increase of skin elasticity and hydration in PLLA-treated subjects and a decrease in transepidermal water loss in both groups. Pigmentation, erythema, and pore size were significantly decre
0.035935s